Global Longlife Hospital and Research Limited share price
BSE: GLHRL
Key numbers
- Market cap
- ₹ 14.7 Cr
- Current price
- ₹ 14.00
- 52-week high / low
- ₹ 27 / 9
- Stock P/E
- -
- Book value
- ₹ 22.6
- Dividend yield
- 0.00%
- ROCE
- -3.9%
- ROE
- -6.8%
- Debt to equity
- 0.00
- Sales growth (3 yrs)
- -
- Profit growth (3 yrs)
- -
- 1-year return
- -45.1%
About Global Longlife Hospital and Research Limited
Global Longlife Hospital and Research Limited, a multi-speciality tertiary care hospital, provides medical and surgical specialities services in India. It offers medical services, such as oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anaesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, GI medicine, gynecology, infectious disease, nephrology, and neurology; and surgical services, including CVTS, joint replacement orthopaedics, spine surgery, general surgery, onco surgery, GI surgery, neurosurgery, ENT, plastic surgery, trauma centre, urology, laparoscopic surgery, gynaecology, dental surgery, and vascular surgery. It also provides radiology services comprising mammography, CT scan, X-ray, ultrasound, endoscopy, and sonography; pathology services, such as microbiology, biochemistry, clinical pathology, cyto pathology, haematology, and serology; and other services that include dialysis, pharmacy, ambulance, dietary, and physiotherapy services. Global Longlife Hospital and Research Limited was incorporated in 2012 and is based in Ahmedabad, India.
Peers in Medical Care Facilities
- Apollo Hospitals Enterprise Limited
- Max Healthcare Institute Limited
- Manipal Health Enterprises Limited
- Aster DM Quality Care Limited
- Fortis Healthcare Limited
- Global Health Limited
- Narayana Hrudayalaya Limited
- Krishna Institute of Medical Sciences Limited
- Rainbow Children's Medicare Limited
- Park Medi World Limited
Data for information only, not investment advice. Prices end of day.